Emilie Ates
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emilie Ates has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Kozyreff
Department of ophthalmology, Cliniques Universitaires Saint-Luc, UCLouvain, avenue Hippocrate 10, 1200 Brussels, Belgium
1 shared publication - Lucie Pothen
Internal Medicine Department, Cliniques Universitaires Saint-Luc, UCLouvain, 1200 Brussels, Belgium
1 shared publication - Paulina Bartoszek
University Hospitals Saint-Luc, Institut Roi Albert II, UCLouvain, Brussels, Belgium
1 shared publication - Pauline Sambon
Internal Medicine Department, Clinique Saint-Luc Bouge, 5004 Namur, Belgium
1 shared publication
Latest Publications
- Open Access
A Case of Unilateral Choroidal Effusion with Secondary Angle-Closure Due to Severe Panuveitis After Anti-SARS-CoV-2 Vaccination
An 87-year-old woman was referred to our ophthalmology ward due to decreased visual acuity and intense right orbital pain, which had been present for four weeks. The anamnesis was not contributory, except that she had been vaccinated against severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) four weeks prior to symptom onset. Her best-corrected visual acuity was hand movements in the right eye and 20/20 in the left eye. Intra-ocular pressure was 34 mmHg and 16 mmHg, respectively. Right eye slit lamp examination revealed palpebral oedema, chemosis, and temporal scleral thickening with conjunctival injection. The cornea was edematous with endothelial precipitates. The anterior chamber was shallow with a closed angle, associated with grade 1+ cells and 1+ flare, according to the SUN grading system. Mild vitreous inflammation was present (grade 0.5+ vitreous cells), and a total choroidal detachment was visible. In the absence of any other plausible cause, unilateral choroidal effusion with secondary angle-closure due to severe panuveitis was considered a possible adverse event following vaccination against SARS-CoV2.
Open AccessA Case of Unilateral Choroidal Effusion with Secondary Angle-Closure Due to Severe Panuveitis After Anti-SARS-CoV-2 Vaccination
An 87-year-old woman was referred to our ophthalmology ward due to decreased visual acuity and intense right orbital pain, which had been present for four weeks. The anamnesis was not contributory, except that she had been vaccinated against severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) four weeks prior to symptom onset. Her best-corrected visual acuity was hand movements in the right eye and 20/20 in the left eye. Intra-ocular pressure was 34 mmHg and 16 mmHg, respectively. Right eye slit lamp examination revealed palpebral oedema, chemosis, and temporal scleral thickening with conjunctival injection. The cornea was edematous with endothelial precipitates. The anterior chamber was shallow with a closed angle, associated with grade 1+ cells and 1+ flare, according to the SUN grading system. Mild vitreous inflammation was present (grade 0.5+ vitreous cells), and a total choroidal detachment was visible. In the absence of any other plausible cause, unilateral choroidal effusion with secondary angle-closure due to severe panuveitis was considered a possible adverse event following vaccination against SARS-CoV2.